Loading...

PE anti-mouse CD206 (MMR) Antibody

Pricing & Availability
Clone
C068C2 (See other available formats)
Regulatory Status
RUO
Other Names
MMR (macrophage mannose receptor), MR (mannose receptor), MRC1
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
C068C2_PE_1_082911
Thioglycollate-elicited BALB/c peritoneal macrophages were surface stained with CD107b (Mac-3) APC, and then intracellularly stained with CD206 (clone C068C2) PE (top) or rat IgG2a, κ PE isotype control (bottom).
  • C068C2_PE_1_082911
    Thioglycollate-elicited BALB/c peritoneal macrophages were surface stained with CD107b (Mac-3) APC, and then intracellularly stained with CD206 (clone C068C2) PE (top) or rat IgG2a, κ PE isotype control (bottom).
  • C068C2_PE_2_082911
See PE spectral data
Cat # Size Price Quantity Check Availability Save
141705 25 µg 104€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
141706 100 µg 240€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD206, also known as mannose receptor (MR), is a 175 kD type I membrane protein. It is a pattern recognition receptor (PRR) belonging to the C-type lectin superfamily. MR is expressed on macrophages, dendritic cells, Langerhans cells, and hepatic or lymphatic endothelial cells. MR recognizes a range of microbial carbohydrates bearing mannose, fucose, or N-acetyl glucosamine through its C-type lectin-like carbohydrate recognition domains, sulfated carbohydrate antigens through its cysteine-rich domain, and collagens through its fibronectin type II domain. MR mediates endocytosis and phagocytosis as well as activation of macrophages and antigen presentation. It plays an important role in host defense and provides a link between innate and adaptive immunity. Recently, MR on lymphatic endothelial cells was found to be involved in leukocyte trafficking and a contributor to the metastatic behavior of cancer cells. It suggests that MR may be a potential target in controlling inflammation and cancer metastasis by targeting the lymphatic vasculature.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Recombinant mouse CD206 (MMR)
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

ICFC - Quality tested
FC - Verified
Recommended Usage

Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume.  It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone C068C2 recognizes a region similar to clone MR5D3, based on the ability of the clones to block each other. Additional reported applications (for the relevant formats) include: spatial biology (IBEX)4,5.

Application References
  1. Keller J, et al. 2012. Biochem Biophys Res Commun. 417:217. PubMed
  2. Ito H, et al. 2012. J Am Soc Nephrol. 23:1797. PubMed
  3. Yang X, et al. 2015. PNAS. 112:2900. PubMed
  4. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  5. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Ukah T, et al. 2017. J Immunol. 10.4049/jimmunol.1700410. PubMed
  2. Clarke F,et al. 2017. PLoS One. 10.1371/journal.pone.0186625. PubMed
  3. Yu Y, et al. 2018. Mol Med Rep. 17:8212. PubMed
  4. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  5. Long L, et al. 2018. Bio Protoc. 8:e2815. PubMed
  6. Krukowski K, et al. 2018. Sci Rep. 8:7857. PubMed
  7. Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
  8. Michela Miani et al. 2018. Cell metabolism. 28(4):557-572 . PubMed
  9. Roediger B et al. 2018. Cell. 175(2):530-543 . PubMed
  10. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  11. Feng Y, et al. 2018. J Am Soc Nephrol. 29:182. PubMed
  12. Ying W et al. 2017. Cell. 171(2):372-384 . PubMed
  13. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  14. Yuan M, et al. 2017. Hum Reprod. 32:94. PubMed
  15. Chu SY, et al. 2019. Nat Commun. 10:1524. PubMed
  16. Li C, et al. 2019. JCI Insight. 5. PubMed
  17. Lee DH, et al. 2019. PLoS One. 14:e0215727. PubMed
  18. El–Achkar GA, et al. 2019. PLoS One. 14:e0216405. PubMed
  19. Li B et al. 2019. Cell reports. 26(10):2720-2737 . PubMed
  20. Morioka S, et al. 2018. Nature. 563:714. PubMed
  21. Wen HJ, et al. 2019. Cell Mol Gastroenterol Hepatol. 8:p173. PubMed
  22. Guérin MV, et al. 2019. Nat Commun. 10:4131. PubMed
  23. Mellal K, et al. 2019. Sci Rep. 9:12903. PubMed
  24. Chuan Li et al. 2017. Endocrinology. 158(9):2837-2847 . PubMed
  25. Seo JB, et al. 2019. Nat Metab. 1:86. PubMed
  26. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  27. An W et al. 2019. British journal of pharmacology. 176(5):699-710 . PubMed
  28. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  29. Ruiz de Azua I, et al. 2017. J Clin Invest. 127:4148. PubMed
  30. Hu S, et al. 2018. Front Immunol. 9:01. PubMed
  31. Bhattacharya A, et al. 2018. Neuropsychopharmacology. 43:2586. PubMed
  32. Sun H, et al. 2019. Mol Hum Reprod. 25:05:00. PubMed
  33. Yuan Y, et al. 2019. Clin Sci (Lond). 133:1759. PubMed
  34. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  35. Giri J, et al. 2020. Cell Rep. 30:1923. PubMed
  36. Liao T, et al. 2017. Front Immunol. 8:1334. PubMed
  37. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  38. Dan H, et al. 2020. Mol Oncol. 14:795. PubMed
  39. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  40. Mul Fedele ML, et al. 2020. Front Cell Infect Microbiol. 10:100. PubMed
  41. Zhang J, et al. 2020. J Cell Mol Med. 24:4547. PubMed
  42. Kim JS, et al. 2020. Int J Oncol. 56:1405. PubMed
  43. Sztwiertnia I, et al. 2020. PLoS One. 15:e0233789. PubMed
  44. Lu SW, et al. 2020. Nat Commun. 3.660416667. PubMed
  45. Farini A, et al. 2020. Front Physiol. 0.738194444. PubMed
  46. Asterholm I, et al. 2012. J Lipid Res. 53: 1254. PubMed
  47. Lu X, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2358. PubMed
  48. Shao H, et al. 2012. J Biol Chem. 287:35860. PubMed
  49. Stridh L, et al. 2013. J Neurosci. 33:12401. PubMed
  50. Moreno M et al. 2014. The Journal of Neuroscience. 34(24):8175-85 . PubMed
  51. Browne A, et al. 2015. Cancer Res . 75: 2811 - 2821. PubMed
  52. Deng W, et al. 2015. Clin Immunol. . PubMed
  53. Nomura M, et al. 2016. Nat Immunol. 17:216-217. PubMed
  54. Ying W, et al. 2016. Sci Rep. 6:20176. PubMed
  55. Zhou K, et al. 2016. J Cereb Blood Flow Metab. 10.1177/0271678X16648712. PubMed
  56. Suzuki T, et al. 2017. Cell Rep. 18(8):2045-2057. PubMed
  57. Leach SM, et al. 2020. Cell Rep. 33:108337. PubMed
  58. Martins L, et al. 2020. Stem Cell Res Ther. 0.786805556. PubMed
  59. Lowe PP, et al. 2020. J Neuroinflammation. 0.913888889. PubMed
  60. Tang TT, et al. 2020. Sci Adv. 6:eaaz0748. PubMed
  61. Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed
  62. Zheng W, et al. 2021. Wellcome Open Research. 6:52. PubMed
  63. Zheng H, et al. 2021. Frontiers in Immunology. 12:645100. PubMed
  64. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  65. Budhu S, et al. 2021. Cell Reports. 34(2):108620. PubMed
  66. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  67. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  68. Dong L, et al. 2021. Cancer Cell. . PubMed
  69. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  70. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  71. He C, et al. 2021. Oncoimmunology. 1897295:10. PubMed
  72. Shu Y, et al. 2020. Immunology. 160:345. PubMed
  73. Sadek J, et al. 2021. EMBO Mol Med. 13:e13591. PubMed
  74. Al-Zaeed N, et al. 2021. Cell Death Dis. 12:611. PubMed
  75. Jia X, et al. 2021. Front Cell Dev Biol. 9:685522. PubMed
  76. Cai C, et al. 2021. Sci Rep. 11:13386. PubMed
  77. Pajarinen J, et al. 2021. J Biomed Mater Res A. 109:1512. PubMed
  78. Golabek A, et al. 2021. Exp Ther Med. 21:482. PubMed
  79. Cui J, et al. 2021. J Cell Mol Med. 25:5586. PubMed
  80. Miura I, et al. 2021. Physiol Rep. 9:e14859. PubMed
  81. Liu YS, et al. 2021. Cancers (Basel). 13:. PubMed
  82. McKee AM, et al. 2021. iScience. 24:103012. PubMed
  83. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  84. Krukowski K, et al. 2021. Sci Adv. 7:eabg6702. PubMed
  85. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  86. Budai Z, et al. 2021. Cells. 10:. PubMed
  87. Tripathi H, et al. 2020. J Mol Cell Cardiol. 149:95. PubMed
  88. Mehta AK, et al. 2021. Nat Cancer. 2:66. PubMed
  89. Yeini E, et al. 2021. Nat Commun. 12:1912. PubMed
  90. Li J, et al. 2021. Front Immunol. 12:649285. PubMed
  91. Guo S, et al. 2021. Chronic Dis Transl Med. 7:254. PubMed
  92. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  93. Qiu N, et al. 2021. J Nanobiotechnology. 19:428. PubMed
  94. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  95. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  96. Zhang B, et al. 2022. Front Med (Lausanne). 8:796743. PubMed
  97. Golden TN, et al. 2022. Front Pharmacol. 12:761496. PubMed
  98. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  99. Liu C, et al. 2022. Cell Death Discov. 8:269. PubMed
  100. Johansen AZ, et al. 2022. Pharmaceutics. 14:. PubMed
  101. Wang HH, et al. 2022. J Biomed Sci. 29:36. PubMed
  102. Li Y, et al. 2020. Theranostics. 10:2897. PubMed
  103. Lu X, et al. 2020. Sci Transl Med. 12:. PubMed
  104. Lal JC, et al. 2021. Breast Cancer Res. 23:83. PubMed
  105. Li Q, et al. 2021. Front Immunol. 12:707784. PubMed
  106. Li J, et al. 2021. Cell Commun Signal. 19:89. PubMed
  107. Hou H, et al. 2021. Front Cell Dev Biol. 9:737003. PubMed
  108. Wang X, et al. 2022. J Biol Chem. 298:101561. PubMed
  109. Tanner L, et al. 2022. Front Pharmacol. 13:899469. PubMed
  110. Di Lorenzo A, et al. 2022. Oncoimmunology. 11:2086752. PubMed
  111. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  112. Zhang Y, et al. 2022. Nat Commun. 13:4553. PubMed
  113. Zhang Z, et al. 2022. Front Pharmacol. 13:906625. PubMed
  114. Stevenson ER, et al. 2022. J Pharmacol Exp Ther. 382:356. PubMed
  115. Yang C, et al. 2022. Nat Commun. 13:4866. PubMed
  116. Wang Y, et al. 2022. Cell Death Dis. 13:748. PubMed
  117. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  118. De Vlaeminck Y, et al. 2020. Cancers (Basel). 12:. PubMed
  119. Zhang J, et al. 2021. J Leukoc Biol. 110:485. PubMed
  120. Anderson-Baucum E, et al. 2021. Cell Metab. 33:1883. PubMed
  121. Xu GY, et al. 2022. Small. 18:e2107838. PubMed
  122. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  123. Zhu Q, et al. 2022. Atherosclerosis. 357:41. PubMed
  124. Sears SM, et al. 2022. Kidney360. 3:818. PubMed
  125. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  126. Cai T, et al. 2022. Front Immunol. 13:1009932. PubMed
  127. Yu L, et al. 2021. Cell Biol Int. 45:2452. PubMed
  128. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  129. Silveira DB, et al. 2022. Cell Biochem Funct. 40:163. PubMed
  130. Liang X, et al. 2022. Cancer Commun (Lond). 42:205. PubMed
  131. Lee R, et al. 2022. Cancer Discov. 12:1702. PubMed
  132. Wang S, et al. 2022. Sci Adv. 8:eabn3883. PubMed
  133. Li D, et al. 2022. Cell Prolif. 55:e13299. PubMed
  134. Li Y, et al. 2023. Bioact Mater. 20:548. PubMed
  135. Liu Z, et al. 2022. Cancer Commun (Lond). 42:971. PubMed
  136. Meng Z, et al. 2022. Int J Oncol. 61: . PubMed
  137. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  138. Li J, et al. 2023. Front Immunol. 13:945234. PubMed
  139. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  140. Domingos-Pereira S, et al. 2022. Int J Mol Sci. 24: . PubMed
  141. Li Y, et al. 2023. Cell Death Dis. 14:28. PubMed
  142. Zhang L, et al. 2023. J Inflamm Res. 16:109. PubMed
  143. Fan R, et al. 2023. J Immunother Cancer. 11: . PubMed
  144. Chun J, et al. 2023. Cancers (Basel). 15: . PubMed
  145. Li S, et al. 2023. Exp Mol Med. 55:457. PubMed
  146. Zhao X, et al. 2022. Cell Mol Immunol. 19:540. PubMed
  147. Lundahl MLE, et al. 2022. Elife. 11:. PubMed
  148. Adzika GK, et al. 2023. Front Immunol. 14:1124649. PubMed
  149. Bautista CA, et al. 2023. Front Physiol. 14:1122348. PubMed
  150. Garabuczi É, et al. 2023. Front Immunol. 14:1139204. PubMed
  151. Chung JY, et al. 2023. Nat Commun. 14:1794. PubMed
  152. Shi Y, et al. 2023. Nat Commun. 14:1884. PubMed
  153. Pan C, et al. 2023. Front Bioeng Biotechnol. 11:1129187. PubMed
  154. Levra Levron C, et al. 2023. Nat Cell Biol. 25:740. PubMed
  155. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  156. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  157. Salemme V, et al. 2023. Nat Commun. 14:2350. PubMed
  158. Zeng S, et al. 2023. Front Oncol. 13:1171926. PubMed
RRID
AB_10896421 (BioLegend Cat. No. 141705)
AB_10895754 (BioLegend Cat. No. 141706)

Antigen Details

Structure
Type I transmembrane protein, 175 kD, C-type lectin superfamily
Distribution

Macrophages, dendritic cells, Langerhans cells, liver endothelial cells

Function
Pathogen recognition, endocytosis and phagocytosis, antigen presentation
Ligand/Receptor
Antigen containing mannose, fucose, or an N-acetyl glucosamine
Cell Type
Dendritic cells, Endothelial cells, Langerhans cells, Macrophages
Biology Area
Cell Biology, Immunology, Innate Immunity, Signal Transduction
Molecular Family
CD Molecules
Antigen References

1. Wileman TE, et al. 1986. P. Natl. Acad. Sci. USA 83:2501.
2. Apostolopoulos V, et al. 2001. Curr. Mol. Med. 1:469.
3. Burgdorf S, et al. 2006. J. Immunol. 176:6770.
4. McKenzie EJ, et al. 2007. J. Immunol. 178:4975.

Gene ID
17533 View all products for this Gene ID
UniProt
View information about CD206 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Why is mouse CD206 stained intracellularly and not via surface staining?

Typically, mouse CD206 surface level is relatively low under normal conditions and so intracellular staining protocol is required to get better signal.

Go To Top Version: 3    Revision Date: 04.04.2016

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account